Loading…
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2
Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relati...
Saved in:
Published in: | Cancer research (Chicago, Ill.) Ill.), 2005-06, Vol.65 (11), p.4852-4860 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3 |
container_end_page | 4860 |
container_issue | 11 |
container_start_page | 4852 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 65 |
creator | AHMED-BELKACEM, Abdelhakim POZZA, Alexandre MUNOZ-MARTINEZ, Francisco BATES, Susan E CASTANYS, Santiago GAMARRO, Francisco DI PIETRO, Attilio PEREZ-VICTORIA, José M |
description | Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport. |
doi_str_mv | 10.1158/0008-5472.CAN-04-1817 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00313594v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67891290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</originalsourceid><addsrcrecordid>eNpFkd2OEyEcxYnRuHX1ETTcaOLFrHwOcNlt3F2TRm_0mlD4T4qZzlRgmsyr-LQytuleAYffOXwchN5Tckep1F8IIbqRQrG7zfp7Q0RDNVUv0IpKrhslhHyJVlfmBr3J-XddSkrka3RDpeGEk3aF_j707jQOYww4lzT5MiVonC_xFMtcpSlEyDgGGErsZtw2xwTD3Pt9mnMcsBsCLuDLeBUyPo6l0v-38hF87KLHcdjHXSxjynjs8C6BywV7N3hIOEGOuSxzfEzVW1PW95tH9ha96lyf4d1lvEW_Hr7-3Dw12x-P3zbrbeOFlqoRToAgRreKKcmZd9rw-j6mOFOMKaJDZ0JoveqgYwE8GOkFaYMKzDDHgN-iz-fcvevtMcWDS7MdXbRP661dNEI45dKIE63spzNbb_pnglzsIWYPfe8GGKdsW6UNZYZUUJ5Bn8acE3TXZErsUqBdyrFLObYWaImwS4HV9-FywLQ7QHh2XRqrwMcL4LJ3fZfqx8X8zLVatsYo_g-teaXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67891290</pqid></control><display><type>article</type><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><source>EZB Electronic Journals Library</source><creator>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</creator><creatorcontrib>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</creatorcontrib><description>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-04-1817</identifier><identifier>PMID: 15930306</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Acridines - pharmacology ; Adenosine Triphosphatases - metabolism ; Antineoplastic agents ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; ATP-Binding Cassette Transporters - antagonists & inhibitors ; ATP-Binding Cassette Transporters - genetics ; Benzimidazoles - pharmacokinetics ; Biochemistry, Molecular Biology ; Biological and medical sciences ; Cell Line ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Flavonoids - chemistry ; Flavonoids - pharmacology ; Humans ; Life Sciences ; Medical sciences ; Mitoxantrone - pharmacokinetics ; Mitoxantrone - pharmacology ; Multidrug Resistance-Associated Proteins - metabolism ; Neoplasm Proteins - antagonists & inhibitors ; Neoplasm Proteins - genetics ; Pharmacology. Drug treatments ; Rhodamines - pharmacokinetics ; Structure-Activity Relationship ; Tetrahydroisoquinolines - pharmacology ; Transfection ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4852-4860</ispartof><rights>2005 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</citedby><cites>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</cites><orcidid>0000-0001-6489-5091</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16856997$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15930306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00313594$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>AHMED-BELKACEM, Abdelhakim</creatorcontrib><creatorcontrib>POZZA, Alexandre</creatorcontrib><creatorcontrib>MUNOZ-MARTINEZ, Francisco</creatorcontrib><creatorcontrib>BATES, Susan E</creatorcontrib><creatorcontrib>CASTANYS, Santiago</creatorcontrib><creatorcontrib>GAMARRO, Francisco</creatorcontrib><creatorcontrib>DI PIETRO, Attilio</creatorcontrib><creatorcontrib>PEREZ-VICTORIA, José M</creatorcontrib><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</description><subject>Acridines - pharmacology</subject><subject>Adenosine Triphosphatases - metabolism</subject><subject>Antineoplastic agents</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</subject><subject>ATP Binding Cassette Transporter, Subfamily G, Member 2</subject><subject>ATP-Binding Cassette Transporters - antagonists & inhibitors</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>Benzimidazoles - pharmacokinetics</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Drug Resistance, Neoplasm</subject><subject>Flavonoids - chemistry</subject><subject>Flavonoids - pharmacology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Mitoxantrone - pharmacokinetics</subject><subject>Mitoxantrone - pharmacology</subject><subject>Multidrug Resistance-Associated Proteins - metabolism</subject><subject>Neoplasm Proteins - antagonists & inhibitors</subject><subject>Neoplasm Proteins - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Rhodamines - pharmacokinetics</subject><subject>Structure-Activity Relationship</subject><subject>Tetrahydroisoquinolines - pharmacology</subject><subject>Transfection</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkd2OEyEcxYnRuHX1ETTcaOLFrHwOcNlt3F2TRm_0mlD4T4qZzlRgmsyr-LQytuleAYffOXwchN5Tckep1F8IIbqRQrG7zfp7Q0RDNVUv0IpKrhslhHyJVlfmBr3J-XddSkrka3RDpeGEk3aF_j707jQOYww4lzT5MiVonC_xFMtcpSlEyDgGGErsZtw2xwTD3Pt9mnMcsBsCLuDLeBUyPo6l0v-38hF87KLHcdjHXSxjynjs8C6BywV7N3hIOEGOuSxzfEzVW1PW95tH9ha96lyf4d1lvEW_Hr7-3Dw12x-P3zbrbeOFlqoRToAgRreKKcmZd9rw-j6mOFOMKaJDZ0JoveqgYwE8GOkFaYMKzDDHgN-iz-fcvevtMcWDS7MdXbRP661dNEI45dKIE63spzNbb_pnglzsIWYPfe8GGKdsW6UNZYZUUJ5Bn8acE3TXZErsUqBdyrFLObYWaImwS4HV9-FywLQ7QHh2XRqrwMcL4LJ3fZfqx8X8zLVatsYo_g-teaXQ</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>AHMED-BELKACEM, Abdelhakim</creator><creator>POZZA, Alexandre</creator><creator>MUNOZ-MARTINEZ, Francisco</creator><creator>BATES, Susan E</creator><creator>CASTANYS, Santiago</creator><creator>GAMARRO, Francisco</creator><creator>DI PIETRO, Attilio</creator><creator>PEREZ-VICTORIA, José M</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-6489-5091</orcidid></search><sort><creationdate>20050601</creationdate><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><author>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acridines - pharmacology</topic><topic>Adenosine Triphosphatases - metabolism</topic><topic>Antineoplastic agents</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</topic><topic>ATP Binding Cassette Transporter, Subfamily G, Member 2</topic><topic>ATP-Binding Cassette Transporters - antagonists & inhibitors</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>Benzimidazoles - pharmacokinetics</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Drug Resistance, Neoplasm</topic><topic>Flavonoids - chemistry</topic><topic>Flavonoids - pharmacology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Mitoxantrone - pharmacokinetics</topic><topic>Mitoxantrone - pharmacology</topic><topic>Multidrug Resistance-Associated Proteins - metabolism</topic><topic>Neoplasm Proteins - antagonists & inhibitors</topic><topic>Neoplasm Proteins - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Rhodamines - pharmacokinetics</topic><topic>Structure-Activity Relationship</topic><topic>Tetrahydroisoquinolines - pharmacology</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AHMED-BELKACEM, Abdelhakim</creatorcontrib><creatorcontrib>POZZA, Alexandre</creatorcontrib><creatorcontrib>MUNOZ-MARTINEZ, Francisco</creatorcontrib><creatorcontrib>BATES, Susan E</creatorcontrib><creatorcontrib>CASTANYS, Santiago</creatorcontrib><creatorcontrib>GAMARRO, Francisco</creatorcontrib><creatorcontrib>DI PIETRO, Attilio</creatorcontrib><creatorcontrib>PEREZ-VICTORIA, José M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AHMED-BELKACEM, Abdelhakim</au><au>POZZA, Alexandre</au><au>MUNOZ-MARTINEZ, Francisco</au><au>BATES, Susan E</au><au>CASTANYS, Santiago</au><au>GAMARRO, Francisco</au><au>DI PIETRO, Attilio</au><au>PEREZ-VICTORIA, José M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>65</volume><issue>11</issue><spage>4852</spage><epage>4860</epage><pages>4852-4860</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15930306</pmid><doi>10.1158/0008-5472.CAN-04-1817</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6489-5091</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4852-4860 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_00313594v1 |
source | EZB Electronic Journals Library |
subjects | Acridines - pharmacology Adenosine Triphosphatases - metabolism Antineoplastic agents ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism ATP Binding Cassette Transporter, Subfamily G, Member 2 ATP-Binding Cassette Transporters - antagonists & inhibitors ATP-Binding Cassette Transporters - genetics Benzimidazoles - pharmacokinetics Biochemistry, Molecular Biology Biological and medical sciences Cell Line Cell Line, Tumor Drug Resistance, Neoplasm Flavonoids - chemistry Flavonoids - pharmacology Humans Life Sciences Medical sciences Mitoxantrone - pharmacokinetics Mitoxantrone - pharmacology Multidrug Resistance-Associated Proteins - metabolism Neoplasm Proteins - antagonists & inhibitors Neoplasm Proteins - genetics Pharmacology. Drug treatments Rhodamines - pharmacokinetics Structure-Activity Relationship Tetrahydroisoquinolines - pharmacology Transfection Tumors |
title | Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A27%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flavonoid%20structure-activity%20studies%20identify%206-prenylchrysin%20and%20tectochrysin%20as%20potent%20and%20specific%20inhibitors%20of%20breast%20cancer%20resistance%20protein%20ABCG2&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=AHMED-BELKACEM,%20Abdelhakim&rft.date=2005-06-01&rft.volume=65&rft.issue=11&rft.spage=4852&rft.epage=4860&rft.pages=4852-4860&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-04-1817&rft_dat=%3Cproquest_hal_p%3E67891290%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67891290&rft_id=info:pmid/15930306&rfr_iscdi=true |